This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): KB9520, ERbeta agonist
Description: KB9520 targets the estrogen receptor beta (ERbeta).
The compound has shown efficacy in different forms of cancer. In these disease models, the treatment has demonstrated to significantly reduce tumor size due to the substance’s anti-proliferative and pro-apoptotic effects.
Pink Sheet Top Partnering Opportunities In Neuroscience
Additional information available to subscribers only: